Study of DAC Combined With HAAG Regimen in Newly Diagnosed AML Patients Older Than 60

NCT04083911 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia
Induction Chemotherapy

Interventions

DRUG: Decitabine, Homoharringtonine, Aclarubicin, Cytarabine and G-CSF

Sponsor

The First Affiliated Hospital of Soochow University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]